Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


NDMC101


Catalog Number Pack Size List Price* Quantity
HY-124958-5MG 5 mg Inquire
HY-124958-25MG 25 mg Inquire
HY-124958-10MG 10 mg Inquire
HY-124958-50MG 50 mg Inquire
HY-124958-100MG 100 mg Inquire

* CHF, excl. 7.7% VAT and shipping costs


Product Description

NDMC101 is a potent osteoclastogenesis inhibitor and inhibits osteoclast differentiation via down-regulation of NFATc1-modulated gene express. NDMC101 is similar to the DPP4 substrate and is a significant inhibitor of early T-cell activation via DPP4 inhibition. NDMC101can be used for study of bone disorders, such as rheumatoid arthritis, and synovial inflammation et al.

Category Biochemicals
Supplier MedChem Express
Application Metabolism-protein/nucleotide metabolism
Regulatory Status RUO
Grade Clinical information: No Development Reported
Molecular Formula C13H9ClFNO2
Molecular Weight 265.67
CAS-Number [1308631-40-4]
Storage Conditions Please store the product under the recommended conditions in the Certificate of Analysis.
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland